Clinical Development Lead, RNAi Therapeutics (Hybrid)

Alnylam Pharmaceuticals; Philadelphia (Philadelphia County); Hybrid; USD 255,000 - 345,000; Full time

Benefits offered by this job

Medical insurance

Dental insurance

Vision coverage

401(k) match

Paid time off

Job summary

Alnylam Pharmaceuticals seeks an imaginative physician drug developer to lead the clinical program for RNAi therapeutics. The role integrates oversight of trial design, regulatory strategy, and external collaboration within a matrix organization across Regulatory, Biostatistics, Clinical Operations, Preclinical, Commercial & Quality Assurance.

The hybrid position requires 2 onsite days per week in Cambridge, MA or Philadelphia, PA, with strong leadership, scientific vision and stakeholder

Qualifications

• MD or MD PhD with strong research or clinical training and publications.
• Board certification in cardiology or equivalent.
• Experience in clinical research, biostatistics, and regulatory practices.

Responsibilities

• Provide strategic leadership for the clinical program and regulatory strategy.
• Oversee trial conduct, safety, and timely deliverables.
• Collaborate across Research, Regulatory, Medical Affairs and Operations.

Skills

MD/MDPhD

Leadership

Cardiology board cert.

Heart failure/amyloidosis

Clinical trial design

Communication skills

Biotech partnerships

Education

MD or MD/PhD

Job description

Alnylam Pharmaceuticals seeks an imaginative physician drug developer to lead the clinical program for RNAi therapeutics. The role integrates oversight of trial design, regulatory strategy, and external collaboration within a matrix organization across Regulatory, Biostatistics, Clinical Operations, Preclinical, Commercial & Quality Assurance.

The hybrid position requires 2 onsite days per week in Cambridge, MA or Philadelphia, PA, with strong leadership, scientific vision and stakeholder